Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02830750 · ClinicalTrials.gov registry record
Low Fluoroscopy Afib Ablation Registry
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 160
- Enrollment target
NCT02830750: Completed study, sponsored by Stanford University.
NCT02830750 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02830750 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
Prospective data collection of patients undergoing Atrial Fibrillation Ablation.
Primary Outcome
Determine Atrial Fibrillation burden at 12 month visit by reviewing monitoring systems that capture this data
Interventions
- PROCEDURE Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-04 |
What the finished NCT02830750 record still lists
NCT02830750 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Ablation is the first listed.
NCT02830750 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02830750 about?
NCT02830750 is a clinical study titled "Low Fluoroscopy Afib Ablation Registry". Prospective data collection of patients undergoing Atrial Fibrillation Ablation.
What is the current status of trial NCT02830750?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2016-04. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02830750?
The interventions under investigation include: Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT02830750?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia